Aslan Pharms Stock Price, News & Analysis
Company Description
Aslan Pharms (NASDAQ: ASLN) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.7M, ranking #7,033 among all listed U.S. companies by market cap.
ASLN stock has declined 96.5% over the past year. Shares last traded at $0.6000.
This page provides a comprehensive overview of ASLN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aslan Pharms (ASLN) stock last traded at $0.6000. Over the past 12 months, the stock has lost 96.5%. At a market capitalization of $1.7M, ASLN is classified as a micro-cap stock with approximately 2.8M shares outstanding.
ASLN Rankings
Latest News
Aslan Pharms has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, clinical trial. View all ASLN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ASLN Company Profile & Sector Positioning
Aslan Pharms (ASLN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.